Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy

Brain and Development

Volumn 19, Issue 1, 1997, Pages 35-42

  Yamamoto, Tomoko ^a   Toyoda, Chisato ^a   Kobayashi, Makio ^a   Kondo, Eri ^a   Saito, Kayoko ^a   Osawa, Makiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fetus; Fukuyama congenital muscular dystrophy; Immunohistochemistry; Pial glial barrier

Indexed keywords

PROTEIN S 100;

ARTICLE; BRAIN STEM; CASE REPORT; CEREBELLUM; ELECTRON MICROSCOPY; FEMALE; FETUS; GLIA; GRANULAR CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEPTOMENINX; MICROSCOPY; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; NEURITE; NONHUMAN; PIA MATER;

BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; FEMALE; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MUSCULAR DYSTROPHIES; NEUROGLIA; PIA MATER; SPINAL CORD;

EID: 0031051605     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(96)00056-3     Document Type: Article

References (21)

1. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Report of fifteen cases. Pediatr. Univ. Tokyo (Tokyo) 1960; 4: 5-8.
2. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type. Clinical, genetic and pathological considerations. Brain Dev. (Tokyo) 1981; 3: 1-29.
3. Kamoshita S, Konishi Y, Segawa M, Fukuyama Y. Congenital muscular dystrophy as a disease of the central nervous system. Arch. Neural. 1976; 33: 513-516.
4. Osawa M, Suzuki N, Arai Y, et al. Fukuyama type congenital progressive muscular dystrophy (FCMD). Special comment on the relationship between the case reported by Nakayama et al and FCMD. Neuropathology (Tokyo) 1993; 13: 259-268.
5. Takada K, Nakamura H, Tanaka. Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). J. Neuropathol. Exp. Neurol. 1984; 43: 395-407.
6. Sarnat HB. Cerebral dysgenesis. Embryonal and Clinical Expression. New York: Oxford University Press, 1992: 245-274.
7. Takada K. Fukuyama congenital muscular dystrophy as a unique disorder of neuronal migration: a neuropathological review and hypothesis. Yonago Acta Med. (Yonago) 1988; 31: 1-16.
8. Takada K, Nakamura H, Suzumori K, Ishikawa T, Sugiyama N. Cortical dysplasia in a 23-week fetus with Fukuyama congenital uscular dystrophy (FCMD). Acta Neuropathol. 1987; 74: 300-306.
9. Nakano I, Funahashi M, Takada K, et al. Are branches of the glia limitans the primary cause of the micropolygyria of Fukuyamatype congenital muscular dystrophy (FCMD)? - Pathological study of the cerebral cortex of a FCMD fetus. Acta Neuropathol. 1996; 91: 313-321.
10. Yamamoto T, Komori T, Shibata N et al. Fukuyama congenital muscular dystrophy: cortical dysplasia of the cerebrum in a 20-week fetus. Neuropathology (Tokyo), in press.
11. Kondo E, Saito K, Toda T, Osawa M, Fukuyama Y. Prenatal diagnosis in Fukuyama type congenital muscular dystrophy by polymorphisms analysis. Am. J. Med. Genet., in press.
12. Toda T, Segawa M, Nomura Y et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat. Genet. 1993; 5: 283-286.
13. Toda T, Ikegawa S, Okui K et al. Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: Evidence for strong linkage disequilibrium. Am. J. Hum. Genet. 1994; 55: 946-950.
14. Friede RL. Developmental Neuropathology, 2nd edn. Berlin: Springer-Verlag, 1989; 2-20, 330-346.
15. Brun A. Marginal glioneural heterotopias of the central nervous system. Acta Pathol. Microbiol. Scand. 1965; 65: 221-233.
16. Sidman RL, Rakic P. Neuronal migration, with special reference to developing human brain: A review. Brain Res. 1973; 62: 1-35.
17. Pehlemann FW, Sievers J, Berry M. Meningeal cells are involved in foliation, lamination, and neurogenesis of the cerebellum: evidence from 6-hydroxydopamine-induced destruction of meningeal cells. Dev. Biol. 1985; 110: 136-146.
18. Sievers J, Von Knebel Doeberitz C, Pehlemann FW, Berry M. Meningeal cells influence cerebellar development over a critical period. Anat. Embryol. 1986; 175: 91-100.
19. Von Knebel Doeberitz C, Sievers J, Sadler M, Pehlemann FW, Berry M, Halliwell P. Destruction of meningeal cells over the new born hamster cerebellum with 6-hydroxydopamine prevents foliation and lamination in the rostral cerebellum. Neuroscience 1986; 17: 409-426.
20. Matsumura K, Campbell KP. Dystrophin-glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 1994; 17: 2-15.
21. Hayashi YK, Engvall E, Arahata-Hirasawa E et al. Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 1993; 119: 53-64.